Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -3.846M
March 31, 2026 -19.14M
December 31, 2025 -13.34M
September 30, 2025 -9.166M
June 30, 2025 -6.037M
March 31, 2025 -7.659M
December 31, 2024 -14.51M
September 30, 2024 5.067M
June 30, 2024 0.955M
March 31, 2024 -17.33M
December 31, 2023 -5.491M
September 30, 2023 -7.906M
June 30, 2023 -6.411M
March 31, 2023 -6.361M
December 31, 2022 -5.886M
September 30, 2022 -6.78M
Date Value
June 30, 2022 -7.482M
March 31, 2022 -8.169M
December 31, 2021 -10.46M
September 30, 2021 -10.03M
June 30, 2021 -7.336M
March 31, 2021 -8.402M
December 31, 2020 -9.144M
September 30, 2020 -8.835M
June 30, 2020 -6.206M
March 31, 2020 -5.901M
December 31, 2019 -9.30M
September 30, 2019 -4.26M
June 30, 2019 -6.960M
March 31, 2019 -4.408M
December 31, 2018 -4.137M
September 30, 2018 -3.205M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.567M
Amgen, Inc. 2.375B
Anika Therapeutics, Inc. 3.309M
BioCryst Pharmaceuticals, Inc. 78.40M
Imunon, Inc. -2.814M